Home
关于我们
产品中心
新闻资讯
技术文章
定制合成
联系我们
中文
产品中心
PRODUCTS
Current location:
Home
>>
产品中心
>>
抗体
PRODUCT CLASSIFICATION
News
NEWS
Application of bioactive small molecules in disease research
Green intelligence creates industry trends, Fuzhen Biology promotes low-carbon development of fine chemical industry
The monoclonal antibody industry is developing rapidly, and Fuzhen Biotechnology is improving its supply system for monoclonal antibody related raw materials
The global biopharmaceutical market continues to expand
Molecular building blocks are used as accelerators for the development of new drugs
Structural formula
Art.No.
Name
CAS
Pureness
CFZ02058
Durvalumab
1428935-60-7
95%
CFZ02057
Evinacumab
1446419-85-7
95%
CFZ02056
Remtolumab
1791410-27-9
95%
CFZ02054
Vanucizumab
1448221-05-3
95%
CFZ02052
Begelomab
1403744-56-8
95%
CFZ02051
Pasotuxizumab
1442657-12-6
95%
CFZ02050
Avelumab
1537032-82-8
95%
CFZ02049
Lokivetmab
1533403-95-0
95%
CFZ02048
Firivumab
1443004-15-6
95%
CFZ02045
Lacutamab
2187368-16-5
95%
Home
<<
···
52
53
54
55
56
···
54/59
>>
Last
QQ
QQ
Service Hotline:
15111215862
18229892877